People
Ana Catarina Silva
senior researcher
Research Group
Position
Associate Professor (since 2021)
CV
Personal Website
Email
anacatsil@gmail.com
Phone number
-
ORCID
Ciência Vitae
Recent publications
- ACCorreia; JNMoreira; JMSousa Lobo; ACSilva. 2023. Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery. Expert Opinion on Drug Delivery, DOI: 10.1080/17425247.2023.2274902
- Cláudia Pina Costa; Laura Nižić Nodilo; Renata Silva; Eva Martins; Dijana Zadravec; Livije Kalogjera; João Nuno Moreira; José Manuel Sousa Lobo; Anita Hafner; Ana Catarina Silva. 2023. In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model. INTERNATIONAL JOURNAL OF PHARMACEUTICS, DOI: 10.1016/j.ijpharm.2023.123345
- S. Cunha and M. Swedrowska and Y. Bellahnid and Z. Xu and J.M. Sousa Lobo and Ben Forbes and A.C. Silva. 2022. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 620, DOI: 10.1016/j.ijpharm.2022.121720
- Cláudia Pina Costa, João Nuno Moreira, José Manuel Sousa Lobo, Ana CatarinaSilva. 2021. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharmaceutica Sinica B, DOI: 10.1016/j.apsb.2021.02.012
- Ana Catarina Silva, João Nuno Moreira, José Manuel Sousa Lobo, Hugo Almeida. 2020. Current Applications of Pharmaceutical Biotechnology. SpringerPlus, DOI: 10.1007/978-3-030-40464-2
- CCosta; JNMoreira; MHAmaral; JMSousa Lobo; ACSilva. 2019. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. JOURNAL OF CONTROLLED RELEASE, 295, DOI: 10.1016/j.jconrel.2018.12.049
- Garcês, A.; Amaral, M.H.; Lobo, J.M. S; Silva, A. C.. 2017. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 112, DOI: 10.1016/j.ejps.2017.11.023
- Garcês, A.; Amaral, M.H.; Lobo, J.M. S; Silva, A. C.. 2017. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 112, DOI: 10.1016/j.ejps.2017.11.023
- Silva, AC; González-Mira, E; García, ML; Egea, MA; Fonseca, J; Silva, R; Santos, D; Souto, EB; Ferreira, D. 2011. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound. COLLOIDS AND SURFACES B-BIOINTERFACES, 86(1), DOI: 10.1016/j.colsurfb.2011.03.035
Main research interests
- Development of lipid nanoparticles (SLN and NLC) formulations for nose-to-brain and cutaneous delivery
- Using the quality-by-design (QbD) approach to optimize formulations of lipid-based nanosystems
- Delivery systems for biopharmaceuticals
- Development of Advanced Therapy Medicinal Products (ATMPs)